NewEdge Wealth LLC Sells 18,855 Shares of CVS Health Corporation $CVS

NewEdge Wealth LLC cut its holdings in CVS Health Corporation (NYSE:CVS) by 52.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 16,899 shares of the pharmacy operator’s stock after selling 18,855 shares during the period. NewEdge Wealth LLC’s holdings in CVS Health were worth $1,327,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of CVS. Harbor Capital Advisors Inc. grew its holdings in CVS Health by 72.1% during the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 142 shares during the period. Corundum Trust Company INC purchased a new position in shares of CVS Health during the 3rd quarter valued at about $29,000. Front Row Advisors LLC grew its stake in shares of CVS Health by 436.5% during the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock valued at $31,000 after acquiring an additional 371 shares during the period. SOA Wealth Advisors LLC. increased its holdings in CVS Health by 36.9% in the 3rd quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock worth $37,000 after acquiring an additional 131 shares in the last quarter. Finally, Twin Peaks Wealth Advisors LLC bought a new stake in CVS Health during the 2nd quarter worth approximately $36,000. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Trading Down 0.9%

Shares of CVS opened at $76.64 on Monday. The stock has a market capitalization of $97.50 billion, a PE ratio of 55.53, a P/E/G ratio of 0.80 and a beta of 0.50. The company’s fifty day moving average is $78.52 and its 200 day moving average is $76.87. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.63 and a current ratio of 0.84. CVS Health Corporation has a fifty-two week low of $58.35 and a fifty-two week high of $85.15.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. The business had revenue of $105.69 billion during the quarter, compared to analysts’ expectations of $103.67 billion. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The business’s revenue was up 8.2% on a year-over-year basis. During the same period last year, the company posted $1.19 EPS. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Sell-side analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, February 2nd. Investors of record on Thursday, January 22nd were issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.5%. The ex-dividend date was Thursday, January 22nd. CVS Health’s dividend payout ratio is presently 192.75%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the company. Truist Financial set a $100.00 price target on CVS Health in a research note on Wednesday, December 10th. Piper Sandler reiterated an “overweight” rating and set a $101.00 target price (up previously from $99.00) on shares of CVS Health in a research report on Wednesday, December 10th. Morgan Stanley boosted their price target on CVS Health from $89.00 to $93.00 and gave the stock an “overweight” rating in a report on Wednesday, December 10th. Sanford C. Bernstein restated a “market perform” rating and issued a $91.00 price target on shares of CVS Health in a research note on Tuesday, January 6th. Finally, Argus reduced their price objective on shares of CVS Health from $91.00 to $90.00 and set a “buy” rating on the stock in a research report on Wednesday, January 28th. Nineteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, CVS Health presently has an average rating of “Moderate Buy” and an average price target of $94.91.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.